CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, Inc., a leading AI-driven health technology company and portfolio company of nference, announced today it has received the 2024 MedTech Breakthrough Award ...
Artificial intelligence (AI)-based ECG interpretation outperformed standard pathways for the detection of occlusive ...
Real-world evidence to be presented at the American College of Cardiology Scientific Session 2026 highlights impact of Viz HCM, developed as part of a multi-year agreement with Bristol Myers Squibb, ...
Artificial intelligence (AI)-based ECG interpretation outperformed standard pathways for the detection of occlusive ...
A new clinical study shows that PulseAI’s deep learning AI demonstrates superiority over the Apple Watch ECG in the detection of atrial fibrillation. Results have been accepted for presentation at the ...
BELFAST, Northern Ireland, May 19, 2023 /PRNewswire/ -- PulseAI, a leader in the development of cutting-edge AI-powered ECG software, has released the results of a clinical study that has shown the ...
Anumana’s innovative AI algorithms recognized for their transformative potential in cardiology - the first of which is now commercially available “At Anumana, we are committed to developing ...
This single-centre prospective study included 1,490 patients who had symptoms suggestive of ACS but without an ST elevation on the initial ECG. AI-based ECG interpretation ruled out occlusive MI in 1, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results